CAS 1234479-76-5

6H-​Pyrimido[4,​5-​b]​[1,​4]​benzodiazepin-​6-​one, 5,​11-​dihydro-​2-​[[2-​methoxy-​4-​(4-​methyl-​1-​piperazinyl)​phenyl]​amino]​-​5,​11-​dimethyl-

CAS : 1234479-76-5

Formule : C₂₅H₂₉N₇O₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 459.5435

Ref: IN-DA009CHU

ERK5-IN-1

CAS : 1234479-76-5

ERK5-IN-1

Degré de pureté : ≥95%

Masse moléculaire : 459.54g/mol

Ref: 54-BUP04114

ERK5-IN-1

CAS : 1234479-76-5

ERK5-IN-1

Formule : C₂₅H₂₉N₇O₂

Degré de pureté : 98.0% (Typical Value in Batch COA)

Couleur et forme : pale yellow solid

Masse moléculaire : 459.54g/mol

Ref: 54-BISN0169

ERK5-IN-1

CAS : 1234479-76-5

ERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).

Formule : C₂₅H₂₉N₇O₂

Degré de pureté : 97.70%

Couleur et forme : Solid

Masse moléculaire : 459.54

Ref: TM-T5184

ERK5-IN-1

CAS : 1234479-76-5

ERK5-IN-1 is a chemical compound belonging to the group of epidermal growth factor family. It is an agonist for the epidermal growth factor receptor, which has been shown to be overexpressed in cancer stem cells and in pediatric adrenocortical carcinoma. ERK5-IN-1 also binds to the epidermal growth factor receptor with high affinity and inhibits the expression of other receptors, such as epidermal growth factor receptor, oncoprotein c-Met, and ATP binding cassette transporter A2. ERK5-IN-1 can be used in cancer therapy as a potential drug target because it can inhibit tumor proliferation by blocking kinase signaling pathways.

Formule : C₂₅H₂₉N₇O₂

Degré de pureté : Min. 95%

Masse moléculaire : 459.54 g/mol

Ref: 3D-JZB47976